ZygoFix has developed a proprietary approach to spinal stabilization and spinal fusion. Our zLOCK implant is a unique 3D-Printed implant that utilizes our spine’s natural anatomy for spinal stability.
The system offers all around benefits to the $2.2 billion worldwide addressable spine market.
ZygoFix is a privately held company, founded in 2017 by Professor Yizhar Floman and Uri Arnin.
Improve spinal fusion clinical outcomes in the most minimally invasive fashion by providing solutions aligned with our natural anatomy.
Board of Directors
ZygoFix enjoys the great support of our investor, Trendlines, in all descisions and operation.
Todd Dollinger, Chaiman and CEO of the Trendlines Group and Barak Singer, CEO Trendlines Incubator sit at our board along with co-founders Uri Arnin and Prof. Yizhar Floman.
Todd Dollinger brings decades of medical entrepreneurial experience to ZygoFix. Since 1991, Todd has been intricately involved with medical device start-ups bringing them form ideation to commercialization, IPOs and exits.
Todd is the Chairman and CEO of the Trendlines Group.
Barak Singer has over 15 years of experience in management, business development, investment banking, and venture capital.
Among others, Barak served as VP Business Development at Can-Fite BioPharma (NYSE: CANF) and CEO of its subsidiary Ophthalix, VP Business Development at Xenia Venture Capital, and was a Co-Founder and CEO at Or Capital Healthcare Partners.